纵横研报
Tag

#valuation

24Reports
EUZ.XETRA logo
·医用同位素 ·内部研究

Eckert & Ziegler SE: A Better Business, Not Yet a Better Price

Eckert & Ziegler is a Berlin-based radioisotope specialist supplying generators, isotope products and CDMO services whose Medical segment is becoming the group's real profit engine as radiopharmaceutical oncology increasingly relies on lutetium-177 and actinium-225. 2025 revenue reached €312.0 million with Medical gross margin climbing to 49% and net financial position ending the year at €115.2 million, but 2026 guidance implies only about 3% revenue and adjusted-EBIT growth. Rating Hold: at €14.43 the stock already sits close to its conservative fair-value zone of €11.0–11.8, leaving minimal margin of safety for new buyers.

EUZ.XETRA Eckert & Ziegler SE #Radiopharmaceuticals#Medical Isotopes#Actinium-225#CDMO#German Industrials#Valuation
Hold
UEC.US logo
·核燃料循环 ·内部研究

Uranium Energy Corp: Scarce U.S. Uranium Assets, Priced Ahead of the Proof

Uranium Energy Corp is a U.S. in-situ-recovery uranium miner running the country's only two active ISR production hubs, in Wyoming and South Texas, while building toward a domestic conversion business through its UR&C subsidiary. The balance sheet is genuinely strong, with $489.9 million in cash plus restricted cash and no debt as of April 2026, but five-year operating cash flow totaled roughly negative $192.8 million, 2025 revenue of $66.8 million still came mainly from selling purchased inventory rather than mined output, and shares outstanding rose from 378.5 million to 493.3 million since 2023. Rating Avoid: the licensed U.S. permits and policy tailwinds are real, but at $10.07 the stock already sits above even the report's optimistic per-share fair value of $9.02, leaving no margin of safety.

UEC.US Uranium Energy Corp. #Uranium#In-Situ Recovery#Nuclear Fuel Cycle#U.S. Energy Policy#Dilution Risk#Valuation
Avoid
·精密测量与工业自动化 ·内部研究

Hanwei Technology: Good Technology, Bad Price

Hanwei Technology is a Shenzhen-listed industrial sensing company whose revenue now centers on smart instruments and integrated monitoring solutions rather than the stand-alone gas sensors it is still best known for, with a pending Hong Kong H-share listing adding a live capital-markets catalyst. Full-year 2025 revenue recovered 8.35% and attributable profit jumped 107.1% to CNY 158.8 million, but non-recurring-excluded profit was only CNY 38.6 million and the stock already trades around 75 times trailing earnings and 4.3 times book, well above its own CNY 16-22 ideal-buy range. Rating Avoid: the sensing technology and portfolio cleanup are real, but the price already assumes a cleaner, more proven earnings run rate than five years of weak cash conversion have delivered.

300007.SHE Hanwei Technology Group Co., Ltd. #Gas sensors#Industrial sensing#Smart instruments#H-share listing#Domestic substitution#Valuation
Avoid
GH.US logo
·诊断检测 ·内部研究

Guardant Health: A Rerating Built on a Company in Transition

Guardant Health is a blood-based oncology diagnostics company whose economic center still sits in advanced-cancer therapy selection while its upside narrative has shifted toward Shield, a colorectal-cancer screening test that just won UnitedHealth coverage for 100 million lives. 2025 revenue reached 982 million USD, up 33% year on year, with non-GAAP gross margin improving from 62% to 66%, yet the company still posts negative owner earnings and trades near 17x forward EV/sales, above larger and cash-generative peer Natera. Rating Watch: an excellent liquid-biopsy franchise, but the stock already prices in broad Shield adoption and a faster profit path than has been proven, with the ideal buy zone at 68 to 74 dollars.

GH.US Guardant Health, Inc. #liquid biopsy#oncology diagnostics#Shield screening#companion diagnostics#Natera#colorectal cancer screening#valuation
Watch
·电子材料 ·内部研究

Anji Microelectronics: A High-Quality Compounder, but a Better Company Than Stock

Anji Microelectronics is China's leading CMP-slurry maker, supplying semiconductor polishing slurries and a widening platform of formulated wet electronic chemicals, with 2025 revenue of CNY 2.50bn (up 36%) and a disclosed global CMP-slurry share that climbed from about 7% in 2022 to 13% in 2025. The usage story is genuine: attributable net profit grew 47% to CNY 784m and functional wet chemicals surged 64%, yet after a roughly 161% one-year run the stock trades near CNY 305, about 88 times 2025 earnings, a price that already capitalizes years of flawless execution. Rating Watch: a real hard-tech compounder, but currently a better company than stock, with a serious re-underwriting zone only back at CNY 190-230.

688019.SHG Anji Microelectronics Technology (Shanghai) Co., Ltd. #CMP slurry#semiconductor materials#domestic substitution#wet chemicals#valuation#SUN-R
Watch
SHA.XETRA logo
·汽车零部件 ·内部研究

Schaeffler: More Interesting Than Its Multiple, but Not Yet Safer Than It Implies

Schaeffler is a German motion-technology supplier (bearings, automotive aftermarket, and electrification systems), reshaped into a four-division group after the 2024 Vitesco merger, with 2025 revenue of EUR 23.5 billion. The legacy bearings and aftermarket businesses are better than the stock's distressed-supplier multiple implies, but E-Mobility still ran a -16% adjusted EBIT margin in 2025 and EUR 4.9 billion of net debt keeps the group below investment grade, so the cheap multiple reflects real transition risk rather than hidden value. Rating Watch: buy only at a larger discount (ideal entry EUR 6.2-6.9) or after clearer proof that E-Mobility losses and leverage are turning.

SHA.XETRA Schaeffler AG #auto components#Vitesco merger#E-Mobility#bearings#turnaround#valuation
Watch
UCB.BR logo
·制药 ·内部研究

UCB SA: A Specialty-Biopharma Growth Platform That Has Already Re-Rated

UCB is a Belgian specialty biopharma in immunology and neurology, and BIMZELX is now its largest product at €2.227 billion of 2025 net sales. FY2025 revenue rose 26% to €7.741 billion, adjusted EBITDA jumped to €2.636 billion, and the balance sheet swung from €1.454 billion of net debt to roughly net cash; yet at €258.50, about 24x forward earnings, the price already embeds much of the BIMZELX and portfolio ramp. Rating Hold: a genuinely stronger company at a price that leaves essentially no margin of safety for fresh capital.

UCB.BR UCB SA #BIMZELX#immunology#neurology#specialty biopharma#valuation#pharmaceuticals
Hold
BSY.US logo
·软件与互联网 ·内部研究

Bentley Systems: Durable Infrastructure Compounder, Thin Margin of Safety

Bentley Systems is a specialized infrastructure-engineering software vendor whose economic engine is a recurring estate embedded in civil, utility, and owner-operator workflows, with $1.495 billion ARR, 93% recurring revenue, 99% account retention, and 109% net retention. Full-year 2025 revenue rose 11.0% to $1.502 billion and free cash flow reached $520.2 million, yet a dual-class structure leaves the Bentley Control Group with about 62.8% of voting power and the $30 price sits roughly at conservative fair value. Rating Hold: a high-quality, sticky compounder whose cash conversion the headline P/E understates, but founder control and a thin margin of safety make a fresh buy more attractive below $25.

BSY.US Bentley Systems, Incorporated #Infrastructure software#ARR#Recurring revenue#Digital twin#Moat#Valuation
Hold
·半导体 ·内部研究

Black Sesame International: Credible Challenger, Unproven Cash Conversion

Black Sesame is a fabless designer of automotive compute SoCs, selling ADAS chips and bundled solutions; 2025 revenue rose 73% to RMB822 million, yet it stays deeply loss-making with R&D near 1.7x sales. It has crossed the technical-credibility threshold (A1000 shipping in Geely, BYD and FAW models) but not the cash-conversion one, leaning on repeated 2025-2026 equity raises. Rating Hold: real commercialization exists, but recurring dilution and negative owner earnings cap valuation support, with a true margin of safety only below about HK$6.

2533.HK Black Sesame International Holding Limited #Automotive SoC#ADAS#Autonomous driving#Edge AI#China semiconductors#Valuation
Hold
·工业自动化 ·内部研究

Belimo Holding: A Premium HVAC Compounder Priced for an AI-Cooling Runway

Belimo is the Swiss pure-play leader in HVAC field devices (the actuators, control valves, sensors and meters that regulate heating, cooling and ventilation), selling through contracting and retrofit channels at about 60% of sales and OEM channels at about 40% without competing with the integrated building-automation giants it supplies. In 2025 sales rose 23.3% in local currencies to CHF 1,120.8 million with a 20.8% EBIT margin and 27.8% ROIC, as AI data-center liquid cooling at about 17% of sales became a second growth engine on top of a durable energy-efficiency retrofit franchise, yet at roughly 61x trailing earnings the stock sits near the top of its own historical range. Rating Watch: a genuinely excellent niche compounder whose price already discounts excellence plus a long AI-cooling runway, with a more attractive entry only below roughly CHF 480.

BEAN.SW Belimo Holding AG #HVAC controls#building automation#data-center cooling#liquid cooling#quality compounder#valuation#Switzerland
Watch
·特种化学品 ·内部研究

Sika AG: Quality Compounder in a Cyclical Air Pocket

Sika is the global leader in construction chemicals (admixtures, waterproofing, sealants, roofing and industrial adhesives), selling locally adapted systems through more than 400 factories in over 100 countries, with bolt-on M&A such as Parex and MBCC built into its model. 2025 sales fell 4.8% to CHF 11.20bn on a strong Swiss franc and a soft construction cycle, yet local-currency growth stayed positive and material margin rose to 54.9% while MBCC synergies reached CHF 182m. Rating Hold: a first-rate serial-acquirer compounder caught in a cyclical air pocket, but at roughly 26x trailing earnings the valuation already prices much of the margin recovery before organic growth has returned.

SIKA.SW Sika AG #construction chemicals#specialty chemicals#M&A#MBCC#Switzerland#valuation
Hold
·电力设备 ·内部研究

NARI Technology: Grid-Control Franchise, Quality Already Priced

NARI is the dominant listed proxy for China's grid-control layer: dispatch software, relay protection, UHV control and energy-management systems built around State Grid. 2025 revenue reached RMB 66.23bn with operating cash flow of RMB 12.77bn, yet revenue is outgrowing profit as the mix shifts toward lower-margin storage and outside-grid work. Rating Hold: a high-quality policy-cycle compounder whose roughly 22x trailing valuation leaves little margin of safety against further mix dilution.

600406.SHG NARI Technology Co., Ltd. #grid automation#UHV#smart grid#State Grid#energy storage#valuation
Hold
·电子连接与传感 ·内部研究

AVIC Jonhon Optronic: Defense-Grade Interconnect Leader, Recovery Already Priced

AVIC Jonhon is a Chinese high-reliability interconnect maker whose defense-grade connector core still carries the business (connectors are 98.5% of revenue) while EVs, data centers and optics become the larger growth engine. 2025 revenue edged up 3.4% to RMB 21.39 billion but attributable profit fell 35.6% to about RMB 2.16 billion as defense demand softened and gold, copper and silver costs surged, and at RMB 42.69 the stock already trades on a mid-40s trailing multiple that discounts a recovery while cash conversion stays weak. Rating Hold: the franchise is intact and a rebound is plausible, but today's price pre-spends most of it with no margin of safety.

002179.SHE AVIC Jonhon Optronic Technology Co., Ltd. #connectors#interconnect#defense electronics#data center#EV#valuation
Hold
·医疗器械 ·内部研究

Straumann Holding AG: Dental Platform Leader at a Demanding Price

Straumann is the global leader in specialty dentistry, a Swiss platform that grew from a premium implant maker into a multi-brand, multi-price-point group spanning implants, digital workflows, biomaterials, prosthetics, and clear aligners, with CHF 2.61 billion of 2025 revenue and about 35% of a CHF 6.0 billion implant market. The franchise quality is genuine (ROCE 30.6%, equity ratio 57.6%, a decade of share gains), but gross margin has drifted from 76.2% to 68.6% and free-cash-flow margin from 21.8% to 11.1% as value-tier and digital mix grew, and the stock trades near 35.8x core earnings on a 1.7% free-cash-flow yield. Rating Hold: a high-quality compounder with a long runway, but the price already discounts much of the next margin and ecosystem leg, leaving little margin of safety.

STMN.SW Straumann Holding AG #dental implants#clear aligners#medtech#compounder#valuation#Switzerland
Hold
300274.SHE logo
·电力设备 ·内部研究

Sungrow Power Supply: High-Quality Growth in a Cyclical Shell

Sungrow Power Supply is a founder-led global leader in solar inverters and energy-storage systems, with overseas sales at 60.7% of 2025 revenue and storage now its largest segment at 41.9% of sales. Operating cash flow climbed to CN¥16.9 billion and receivables improved, yet Q1 2026 revenue fell 18.3% and profit 40.1%, exposing sharp margin-mix cyclicality beneath the quality story. Rating Hold: a genuine quality-growth franchise trading at a premium that leaves little margin of safety for execution misses.

300274.SHE Sungrow Power Supply Co., Ltd. #solar inverters#energy storage#renewables#power electronics#China#overseas expansion#valuation
Hold
·工业自动化 ·内部研究

THK: A Category-Defining Linear-Motion Franchise Re-Rated on Restructuring and a Still-Unbooked Robotics Option

THK is the Japanese precision-component maker that commercialized the world's first LM Guide and still leads in linear-motion hardware (LM guides, ball screws, actuators) sold into machine tools, electronics, and factory automation. After exiting a low-return automotive business and adopting an ROE-above-10% policy, continuing-operations earnings are recovering toward 2026 guidance of revenue around 276 billion yen and operating income around 31 billion yen, yet at 7,802 yen the stock trades near 38.5x forward EPS and 3.3x book, pricing in both the restructuring and a robotics optionality the filings do not yet quantify. Rating Hold: a real industrial franchise whose stock has run ahead of delivered execution, with an ideal buy zone of 3,900 to 4,100 yen.

6481.TSE THK Co., Ltd. #Linear Motion#LM Guide#Ball Screw#Industrial Automation#Robot Components#Cyclical#Valuation
Hold
2356.TW logo
·电子制造服务 ·内部研究

Inventec: An AI-Server Manufacturer Still Earning Assembly Margins

Inventec is a Taiwan ODM/EMS maker that has shifted from a notebook-led business to a server-led one, with servers above half of sales on the AI build-out. Q1 2026 revenue rose 28% to NT$200.3 billion, yet gross margin slipped to 5.1% and operating cash flow has converted only about 0.8x of net income over 2021-2025, so AI growth is still monetized through thin, working-capital-heavy assembly economics. Rating Hold: a better business than its old notebook-ODM image, but at NT$67.7 the stock already prices in much of the transition, with a wide margin of safety only opening in the low-to-mid NT$40s.

2356.TW Inventec Corporation #AI server#ODM#EMS#hyperscaler capex#thin margins#valuation
Hold
·精密减速器(谐波减速器·机器人零部件) ·内部研究

Leaderdrive: China's Harmonic-Reducer Leader Priced for a Humanoid Future

Leaderdrive is China's domestic leader in harmonic-drive (strain-wave) reducers, the precision part inside robot joints, now extending from stand-alone components into mechatronic actuators. 2025 revenue jumped 47.3% to RMB 570.7 million with harmonic-reducer unit sales up 72.5%, yet at RMB 381.60 the stock trades near 123x sales and roughly 562x trailing earnings, pre-spending a humanoid-scale future that filings have not yet disclosed. Rating Avoid: a genuinely improving component leader at a speculative price, with every valuation scenario implying a loss from today's level until the humanoid ramp is proven or the price resets.

688017.SHG Leader Harmonious Drive Systems Co., Ltd. #harmonic reducer#precision robotics#humanoid robot#domestic substitution#embodied intelligence#valuation
Avoid
·散热与液冷 ·内部研究

Auras Technology: A Thermal Vendor Climbing the AI Liquid-Cooling Stack

Auras is a Taiwanese thermal-management vendor shifting from legacy air cooling to higher-value AI-server liquid cooling, with 2025 revenue up 47.6% to TWD 23.28 billion. The mix shift is real (2026 Q1 liquid-cooling revenue passed 55% and gross margin reached 29.7%), but 2025 operating cash flow turned negative and the stock near 30.6x trailing earnings already discounts much of the 2026-2027 ramp. Rating Hold: genuine liquid-cooling share gains are visible, yet a wide margin of safety only opens below roughly TWD 690.

3324.TWO Auras Technology Co., Ltd. #thermal management#liquid cooling#AI server#GB300#data center cooling#valuation
Hold
·锂电池与储能 ·In-house Research

LG Energy Solution: Strategic Assets, Unproven Returns

LG Energy Solution is the largest Korean large-format battery maker, running a three-part machine of automotive cells for global OEMs, IRA-localized North American capacity, and a fast-growing energy-storage pivot, with 2025 revenue of ₩23.7tn. The 2026 question is whether it can earn real returns on a ₩42.6tn asset base: Q1 2026 still posted a ₩207.8bn operating loss even after ₩189.8bn of AMPC credits, though 46-series backlog has topped 440 GWh and ESS is becoming a credible second leg. Rating Hold: at ₩404,500 the stock trades near 4.0x sales and already prices a recovery, leaving no clear margin of safety until ex-credit profitability inflects.

373220.KO LG Energy Solution, Ltd. #Battery Manufacturing#Energy Storage#EV Supply Chain#IRA Localization#LFP#Korea#Valuation
Hold
·贵金属(黄金特许权、流式) ·In-house Research

Triple Flag Precious Metals: Quality Compounder, Fully Priced

Triple Flag is a gold-focused streaming and royalty financier that funds miners and collects metal for years at fixed terms, running a 242-asset book at a 93% asset margin with little operating drag. FY2025 revenue reached US$388.7 million with US$312.8 million operating cash flow, yet at US$30.05 the stock trades above its ideal-buy zone, with Northparkes alone at 26% of consensus NAV. Rating Watch: a high-quality compounder still in transition to senior scale, attractive on quality but not yet on price.

TFPM.US Triple Flag Precious Metals Corp. #Gold#Royalty#Streaming#Precious Metals#Compounder#Valuation
Watch
ASAN.US logo
·软件与互联网 ·In-house Research

Asana: Optically Cheap, Strategically Unproven

Asana is a mid-cap, seat-based work-management SaaS now layering consumption-based AI onto a maturing land-and-expand model, with almost all of its $790.8 million FY2026 revenue still tied to the flagship platform. The 2026 story is a clean bull-bear standoff: margins inflected to a $56.7 million FY2026 non-GAAP operating profit and AI products already reached 17% of net-new ARR in Q1 FY2027, yet revenue growth has slowed to high single digits and management still flags PLG as a roughly two-point drag. Rating Watch: the stock is optically cheap at about 1.5x forward EV/revenue, but it needs firmer proof that AI can offset seat-growth maturity before the discount closes.

ASAN.US Asana, Inc. #Work Management#SaaS#AI Monetization#Net Retention#Valuation#Transition
Watch
MRK.XETRA logo
·生命科学工具 ·In-house Research

Merck KGaA: A Diversified Science Platform in Transition

Merck KGaA, Darmstadt is a family-controlled German science-and-technology group whose €21.1 billion of 2025 sales come from three very different engines: a patent-exposed Healthcare arm, a high-quality Life Science tools franchise and a semiconductor-materials Electronics business. The 2026 stock is a tug of war, because a known Mavenclad U.S. patent cliff drags Healthcare while Process Solutions compounds near 10% organically and Electronics rides advanced-node AI demand, leaving the shares near 15.9 times 2025 EPS pre and a 3.5% free-cash-flow yield after a May rebound to €133.05. Rating Hold: genuinely strong Life Science and semiconductor-materials engines offset a credibility-damaged Healthcare arm, but a permanent KGaA governance discount and only-fair valuation keep upside limited.

MRK.XETRA Merck KGaA, Darmstadt, Germany #Life Science Tools#Semiconductor Materials#Pharmaceuticals#KGaA Governance#Conglomerate Discount#Valuation
Hold
·检测与认证服务 ·In-house Research

ALS Limited: A High-Quality Compounder with a Cyclical Sidecar

ALS Limited is a global laboratory-testing group that earns most of its revenue from Life Sciences yet a disproportionate share of margin from minerals-related Commodities testing, so a diversified TIC provider still trades, at key moments, like a high-quality miner's service proxy. FY26 delivered record revenue of A$3.32 billion and an 18.0% underlying EBIT margin, hitting the FY27 strategic targets a year early, but at A$23.36 the stock trades near 37 times trailing EPS with the margin of safety put at zero. Rating Hold: a strong dual-engine testing franchise whose price already discounts commodities strength, acquisition repair and future hub productivity, leaving little room for disappointment.

ALQ.AU ALS Limited #Testing Inspection Certification#Life Sciences#Minerals#Compounder#Australia#Valuation
Hold